Rapporten
Verifierade nyheter om finansiering, huvudkontor och ledarskap från världens mest innovativa företag
77 rapporter och fler
Advanced NanoTherapies Raises Over $31M Series B for Dual-Drug Vascular Balloons
Advanced NanoTherapies announced the closing of an oversubscribed Series B financing of more than $31 million, co-led by S3 Ventures and an undisclosed strategic investor.
Rakuten Medical Raises $100M Series F | Photoimmunotherapy Cancer Treatment
Cancer treatment company Rakuten Medical secures $100 million Series F led by TaiAx for Phase 3 trials.
Corsera Health Raises $80M Series A | Once-Yearly Cardiovascular RNAi
Biotech startup Corsera Health secures $80 million Series A for once-yearly RNAi cardiovascular treatments.
NeuroLink Brain Raises $580M Series D to Transform Healthcare
NeuroLink Brain secures $580M in Series D funding at $8.2B valuation to complete fda approval process, scale manufacturing for clinical deployment, and expand treatment applications.
AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment
Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.
Evommune raises $50M Series B at $300M valuation
Evommune raises $50M in Series B at $300M valuation. Oral immunology treatments...
NRG Therapeutics raises $67M Series B
NRG Therapeutics raises $67M in Series B. Developing treatments for ALS and neurodegenerative diseases...
Kardigan raises $300M Series A
Kardigan raises $300M in Series A. Healthcare company developing innovative treatments for cardiometabolic diseases...
Seaport Therapeutics raises $225M Series C at $1.2B valuation
Seaport Therapeutics raises $225M in Series C at $1.2B valuation. Neuropsychiatric disease treatments...
Visar 9 rapporter • Sida 1 • Kategori: all
Ligga steget före marknaden
Få veckovisa insikter levererade till din inkorg. Ingen spam, bara intelligens.